GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnamed Holdings Corp (XCNQ:DMED) » Definitions » Debt-to-Revenue

Diagnamed Holdings (XCNQ:DMED) Debt-to-Revenue : N/A (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Diagnamed Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Diagnamed Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was C$0.00 Mil. Diagnamed Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was C$0.00 Mil. Diagnamed Holdings's annualized Revenue for the quarter that ended in Dec. 2024 was C$0.00 Mil.


Diagnamed Holdings Debt-to-Revenue Historical Data

The historical data trend for Diagnamed Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnamed Holdings Debt-to-Revenue Chart

Diagnamed Holdings Annual Data
Trend Sep21 Sep22 Sep23 Sep24
Debt-to-Revenue
N/A N/A N/A N/A

Diagnamed Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Diagnamed Holdings's Debt-to-Revenue

For the Health Information Services subindustry, Diagnamed Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnamed Holdings's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnamed Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Diagnamed Holdings's Debt-to-Revenue falls into.


;
;

Diagnamed Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Diagnamed Holdings's Debt-to-Revenue for the fiscal year that ended in Sep. 2024 is calculated as

Diagnamed Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


Diagnamed Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Diagnamed Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnamed Holdings Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.
Executives
Fabio Chianelli Director, Senior Officer

Diagnamed Holdings Headlines

No Headlines